Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APL-R2007: ATO for Relapsed APL
NCT00504764Phase 4Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jul 2007
- Primary completion
- Oct 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by Fundación PETHEMA. Started Jul 2007; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00504764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504764.